BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parr MK, Schmidt AH. Life cycle management of analytical methods. Journal of Pharmaceutical and Biomedical Analysis 2018;147:506-17. [DOI: 10.1016/j.jpba.2017.06.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Gurba-bryśkiewicz L, Dawid U, Smuga DA, Maruszak W, Delis M, Szymczak K, Stypik B, Moroz A, Błocka A, Mroczkiewicz M, Dubiel K, Wieczorek M. Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies. IJMS 2022;23:10720. [DOI: 10.3390/ijms231810720] [Reference Citation Analysis]
2 Ferencz E, Zöldhegyi A, Kelemen ÉK, Obreja M, Urkon M, Sipos E, Tóth G, Molnár I, Szabó ZI. Analytical quality by design-compliant retention modeling for exploring column interchangeabilities in separating ezetimibe and its related substances. J Chromatogr A 2022;1682:463494. [PMID: 36126559 DOI: 10.1016/j.chroma.2022.463494] [Reference Citation Analysis]
3 Bastogne T, Caputo F, Prina-mello A, Borgos S, Barberi-heyob M. A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products. Journal of Pharmaceutical and Biomedical Analysis 2022;219:114911. [DOI: 10.1016/j.jpba.2022.114911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li X, Zhang Z, Harris A, Yang L. Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres. Expert Opin Drug Deliv 2022. [PMID: 35863759 DOI: 10.1080/17425247.2022.2105317] [Reference Citation Analysis]
5 Separovic L, Lourenço FR. Measurement uncertainty evaluation of an analytical procedure for determination of terbinafine hydrochloride in creams by HPLC and optimization strategies using Analytical Quality by Design. Microchemical Journal 2022;178:107386. [DOI: 10.1016/j.microc.2022.107386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bordoloi R, Ahmed AB, Baishya H. Development and Validation of RP-UHPLC Method for Quantification of Gliclazide in Bulk and Pharmaceutical Dosage Form Using Quality-by-Design (QbD) Approach: A Shifting Paradigm. Chromatographia. [DOI: 10.1007/s10337-022-04175-7] [Reference Citation Analysis]
7 Lipari E, Saporiti S, Eberini I, Massimo L, Mazzarella E, Anderloni G, Rossi M, D'Amici F, Pergola C, Palinsky W, D'Acunto CW, Centola F. Asn25 Deamidation as an Allosteric Tool to Increase IFNβ-1a Biological Activity. J Interferon Cytokine Res 2022;42:251-66. [PMID: 35527626 DOI: 10.1089/jir.2021.0209] [Reference Citation Analysis]
8 Kovač L, Časar Z, Trdan Lušin T, Roškar R. Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles. ACS Omega 2022;7:8896-905. [PMID: 35309479 DOI: 10.1021/acsomega.1c07260] [Reference Citation Analysis]
9 Orman E, Assumang A, Oppong-kyekyeku J, Onilimor PJ, Peprah PK, Adu JK, Bekoe SO, Asare-nkansah S. Chromatographic method development for the simultaneous assay of pseudoephedrine hydrochloride and chlorphenamine maleate in oral dosage formulations. Scientific African 2022;15:e01109. [DOI: 10.1016/j.sciaf.2022.e01109] [Reference Citation Analysis]
10 Verch T, Campa C, Chéry CC, Frenkel R, Graul T, Jaya N, Nakhle B, Springall J, Starkey J, Wypych J, Ranheim T. Analytical Quality by Design, Life Cycle Management, and Method Control. AAPS J 2022;24. [DOI: 10.1208/s12248-022-00685-2] [Reference Citation Analysis]
11 Jambo H, Hubert P, Dispas A. Supercritical fluid chromatography for pharmaceutical quality control: Current challenges and perspectives. TrAC Trends in Analytical Chemistry 2022;146:116486. [DOI: 10.1016/j.trac.2021.116486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu X, Xu H, Shang Y, Zhu R, Hong X, Song Z, Yang Z. Development of the general chapters of the Chinese Pharmacopoeia 2020 edition: A review. J Pharm Anal 2021;11:398-404. [PMID: 34513116 DOI: 10.1016/j.jpha.2021.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gurumukhi VC, Bari SB. Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz in Bulk and Tablet Dosage Form using Quality by Design (QbD): A Shifting Paradigm. J Chromatogr Sci 2021:bmab061. [PMID: 34021559 DOI: 10.1093/chromsci/bmab061] [Reference Citation Analysis]
14 Volta E Sousa L, Gonçalves R, Menezes JC, Ramos A. Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review. AAPS PharmSciTech 2021;22:128. [PMID: 33835304 DOI: 10.1208/s12249-021-01960-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Schmidtsdorff S, Neumann J, Schmidt AH, Parr MK. Analytical lifecycle management for comprehensive and universal nitrosamine analysis in various pharmaceutical formulations by supercritical fluid chromatography. J Pharm Biomed Anal 2021;197:113960. [PMID: 33626447 DOI: 10.1016/j.jpba.2021.113960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Płotka-wasylka J, Wojnowski W. Complementary green analytical procedure index (ComplexGAPI) and software. Green Chem 2021;23:8657-65. [DOI: 10.1039/d1gc02318g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
17 Aboushady D, Parr MK, Hanafi RS. Quality-by-Design Is a Tool for Quality Assurance in the Assessment of Enantioseparation of a Model Active Pharmaceutical Ingredient. Pharmaceuticals (Basel) 2020;13:E364. [PMID: 33158197 DOI: 10.3390/ph13110364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Feickert M, Burdman I, Makowski N, Ali M, Bartel A, Burckhardt BB; LENA consortium. A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial. Clin Chem Lab Med 2020;58:1847-55. [PMID: 32049647 DOI: 10.1515/cclm-2019-1162] [Reference Citation Analysis]
19 Feickert M, Burckhardt BB. Validated mass spectrometric assay for the quantification of substance P and human hemokinin-1 in plasma samples: A design of experiments concept for comprehensive method development. J Pharm Biomed Anal 2020;191:113542. [PMID: 32871415 DOI: 10.1016/j.jpba.2020.113542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Žigart N, Časar Z. Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD Principles. ACS Omega 2020;5:17726-42. [PMID: 32715260 DOI: 10.1021/acsomega.0c02338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Enesei D, Kapui I, Fekete S, Kormány R. Updating the European Pharmacopoeia impurity profiling method for terazosin and suggesting alternative columns. J Pharm Biomed Anal 2020;187:113371. [PMID: 32460215 DOI: 10.1016/j.jpba.2020.113371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ambrosio G, Joseph JF, Wuest B, Mazzarino M, de la Torre X, Diel P, Botrè F, Parr MK. Detection and quantitation of ecdysterone in human serum by liquid chromatography coupled to tandem mass spectrometry. Steroids 2020;157:108603. [DOI: 10.1016/j.steroids.2020.108603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Panda SS, Bera VVRK, Viriyala RK. Application of Analytical Lifecycle Management and Monte-Carlo Simulation Approach for Development of a Liquid Chromatography Method for Estimation of Nitazoxanide. Analytical Chemistry Letters 2019;9:789-805. [DOI: 10.1080/22297928.2020.1713211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Tome T, Žigart N, Časar Z, Obreza A. Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances. Org Process Res Dev 2019;23:1784-802. [DOI: 10.1021/acs.oprd.9b00238] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
25 Taladriz-Blanco P, Rothen-Rutishauser B, Petri-Fink A, Balog S. Precision of Taylor Dispersion. Anal Chem 2019;91:9946-51. [PMID: 31246027 DOI: 10.1021/acs.analchem.9b01679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
26 Puschmann J, Evers D, Müller-goymann CC, Herbig ME. Development of a design of experiments optimized method for quantification of polysorbate 80 based on oleic acid using UHPLC-MS. Journal of Chromatography A 2019;1599:136-43. [DOI: 10.1016/j.chroma.2019.04.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Sarkany A, Hancu G, Cârje A, Drăguț C, Papp LA. Chiral separation of tramadol enantiomers by capillary electrophoresis using cyclodextrins as chiral selectors and experimental design method optimization. Chem Pap 2019;73:2363-70. [DOI: 10.1007/s11696-019-00789-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
28 Jackson P, Borman P, Campa C, Chatfield M, Godfrey M, Hamilton P, Hoyer W, Norelli F, Orr R, Schofield T. Using the Analytical Target Profile to Drive the Analytical Method Lifecycle. Anal Chem 2019;91:2577-85. [PMID: 30624912 DOI: 10.1021/acs.analchem.8b04596] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
29 Panda SS, Bera RKVV, Acharjya SK, Sahoo P, Beg S. Analytical lifecycle management approach: Application to development of a reliable LC method for estimation of lacidipine. Sep Sci plus 2019;2:18-25. [DOI: 10.1002/sscp.201800110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
30 Schmidtsdorff S, Schmidt AH, Parr MK. Structure assisted impurity profiling for rapid method development in liquid chromatography. Journal of Chromatography A 2018;1577:38-46. [DOI: 10.1016/j.chroma.2018.09.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
31 Rácz N, Molnár I, Zöldhegyi A, Rieger H, Kormány R. Simultaneous optimization of mobile phase composition and pH using retention modeling and experimental design. Journal of Pharmaceutical and Biomedical Analysis 2018;160:336-43. [DOI: 10.1016/j.jpba.2018.07.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
32 Ancillotti C, Orlandini S, Ciofi L, Pasquini B, Caprini C, Droandi C, Furlanetto S, Del Bubba M. Quality by design compliant strategy for the development of a liquid chromatography–tandem mass spectrometry method for the determination of selected polyphenols in Diospyros kaki. Journal of Chromatography A 2018;1569:79-90. [DOI: 10.1016/j.chroma.2018.07.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
33 Deidda R, Orlandini S, Hubert P, Hubert C. Risk-based approach for method development in pharmaceutical quality control context: A critical review. J Pharm Biomed Anal 2018;161:110-21. [PMID: 30145448 DOI: 10.1016/j.jpba.2018.07.050] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]